Targeted therapy proves effective against brain tumors in preclinical studies
Friday, December 21, 2012 - 13:30
in Health & Medicine
Researchers have published the first evidence that inhibiting focal adhesion kinase with CFAK-Y15 can control the growth of glioblastoma tumors.